TTI
ACHAT TOTAL: 10 000 titres (~65 000,00 $ US)
- Insiders
- John Angela D
- Total bought
- $65,000
- Total sold
- —
- Last activity
- 2026-09-02
- Last synced
-
2026-09-08 09:54:45
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-09-03
TTI presents a weak overall profile: a modest insider cluster buy (single purchase, $65k) paired with conference participation offers insufficient catalytic force to offset deeply fragile fundamentals.
The first sentence of the analysis written for TTI on 2026-09-03 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 25.4% | 23.4% | 22.6% | 20.5% | 15.4% | |
| Ebit Margin | 6.9% | 8.5% | 8.6% | 4.9% | 0.4% | |
| Ebitda Margin | 12.8% | 14.5% | 14.1% | 10.8% | 9.1% | |
| Operating Profit Margin | 9.4% | 8.3% | 7.3% | 4.1% | -3.4% | |
| Pretax Profit Margin | 4.2% | 4.8% | 5.1% | 2.0% | -3.8% | |
| Continuous Operations Profit Margin | 0.7% | 19.0% | 4.1% | 1.4% | -4.3% | |
| Net Profit Margin | 0.5% | 18.1% | 4.1% | 1.4% | -4.3% | |
| Bottom Line Profit Margin | 0.5% | 18.1% | 4.1% | 1.4% | -4.3% | |
| Current Ratio | 2.024 | 2.186 | 2.239 | 1.919 | 2.166 | |
| Quick Ratio | 2.024 | 1.361 | 1.472 | 1.339 | 1.454 | |
| Solvency Ratio | 0.080 | 0.310 | 0.171 | 0.116 | 0.056 | |
| Cash Ratio | 0.288 | 0.302 | 0.417 | 0.109 | 0.325 | |
| Price To Earnings Ratio | 414.602 | 4.366 | 22.714 | 56.536 | -21.402 | |
| Price To Earnings Growth Ratio | -4.264 | 0.014 | 0.101 | -0.387 | 0.318 | |
| Forward Price To Earnings Growth Ratio | -4.264 | 0.014 | 0.101 | -0.387 | 0.318 | |
| Price To Earnings Diluted Ratio | 422.072 | 4.366 | 23.003 | 57.285 | -21.402 | |
| Price To Earnings Diluted Growth Ratio | -4.338 | 0.014 | 0.102 | -0.394 | 0.318 | |
| Price To Book Ratio | 4.399 | 1.846 | 3.941 | 4.118 | 3.606 | |
| Price To Sales Ratio | 1.978 | 0.784 | 0.935 | 0.801 | 0.926 | |
| Price To Free Cash Flow Ratio | 63.878 | -19.453 | 18.271 | -21.004 | -22.647 | |
| Price To Operating Cash Flow Ratio | 12.436 | 12.869 | 8.342 | 23.377 | 77.206 | |
| Debt To Assets Ratio | 0.335 | 0.308 | 0.394 | 0.424 | 0.481 | |
| Debt To Equity Ratio | 0.927 | 0.870 | 1.324 | 1.804 | 1.920 | |
| Debt To Capital Ratio | 0.481 | 0.465 | 0.570 | 0.643 | 0.658 | |
| Long Term Debt To Capital Ratio | 0.430 | 0.414 | 0.515 | 0.592 | 0.604 | |
| Financial Leverage Ratio | 2.767 | 2.823 | 3.362 | 4.252 | 3.994 | |
| Working Capital Turnover Ratio | 4.117 | 3.963 | 4.635 | 4.865 | 3.148 | |
| Operating Cash Flow Ratio | 0.641 | 0.296 | 0.557 | 0.153 | 0.048 | |
| Operating Cash Flow Sales Ratio | 0.159 | 0.061 | 0.112 | 0.034 | 0.012 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.195 | -0.662 | 0.457 | -1.113 | -3.409 | |
| Debt Service Coverage Ratio | 1.779 | 4.785 | 2.545 | 2.254 | 1.351 | |
| Interest Coverage Ratio | 3.437 | 2.225 | 2.038 | 1.440 | -0.805 | |
| Short Term Operating Cash Flow Coverage Ratio | 6.420 | 2.717 | 7.071 | 2.077 | 0.574 | |
| Operating Cash Flow Coverage Ratio | 0.381 | 0.165 | 0.357 | 0.098 | 0.024 | |
| Capital Expenditure Coverage Ratio | 1.242 | 0.602 | 1.840 | 0.473 | 0.227 | |
| Dividend Paid And Capex Coverage Ratio | 1.242 | 0.602 | 1.840 | 0.473 | 0.227 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 18.118 | 7.525 | 8.260 | 10.427 | 14.775 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 25.4% | ▲2.0% | ▲3.9% |
| Ebit Margin | 7.0% | ▼-1.6% | ▲1.1% |
| Ebitda Margin | 12.8% | ▼-1.7% | ▲0.6% |
| Operating Profit Margin | 9.4% | ▲1.1% | ▲4.3% |
| Pretax Profit Margin | 4.2% | ▼-0.6% | ▲1.7% |
| Continuous Operations Profit Margin | 0.7% | ▼-18.3% | ▼-3.5% |
| Net Profit Margin | 0.5% | ▼-17.6% | ▼-3.5% |
| Bottom Line Profit Margin | 0.5% | ▼-17.6% | ▼-3.5% |
| Current Ratio | 2.024 | ▼-0.162 | ▼-0.083 |
| Quick Ratio | 2.024 | ▲0.663 | ▲0.494 |
| Solvency Ratio | 0.080 | ▼-0.230 | ▼-0.067 |
| Cash Ratio | 0.287 | ▼-0.014 | ▼-0.001 |
| Price To Earnings Ratio | 414.602 | ▲410.236 | ▲319.239 |
| Price To Earnings Growth Ratio | -4.263 | ▼-4.277 | ▼-3.420 |
| Forward Price To Earnings Growth Ratio | -4.263 | ▼-4.277 | ▼-3.420 |
| Price To Earnings Diluted Ratio | 422.072 | ▲417.706 | ▲325.007 |
| Price To Earnings Diluted Growth Ratio | -4.338 | ▼-4.352 | ▼-3.478 |
| Price To Book Ratio | 4.399 | ▲2.552 | ▲0.817 |
| Price To Sales Ratio | 1.978 | ▲1.194 | ▲0.893 |
| Price To Free Cash Flow Ratio | 63.877 | ▲83.330 | ▲60.069 |
| Price To Operating Cash Flow Ratio | 12.436 | ▼-0.433 | ▼-14.410 |
| Debt To Assets Ratio | 0.335 | ▲0.027 | ▼-0.053 |
| Debt To Equity Ratio | 0.927 | ▲0.058 | ▼-0.442 |
| Debt To Capital Ratio | 0.481 | ▲0.016 | ▼-0.082 |
| Long Term Debt To Capital Ratio | 0.430 | ▲0.016 | ▼-0.081 |
| Financial Leverage Ratio | 2.767 | ▼-0.056 | ▼-0.672 |
| Working Capital Turnover Ratio | 4.117 | ▲0.154 | ▼-0.029 |
| Operating Cash Flow Ratio | 0.641 | ▲0.345 | ▲0.302 |
| Operating Cash Flow Sales Ratio | 0.159 | ▲0.098 | ▲0.083 |
| Free Cash Flow Operating Cash Flow Ratio | 0.195 | ▲0.856 | ▲1.101 |
| Debt Service Coverage Ratio | 1.779 | ▼-3.006 | ▼-0.764 |
| Interest Coverage Ratio | 3.437 | ▲1.212 | ▲1.770 |
| Short Term Operating Cash Flow Coverage Ratio | 6.420 | ▲3.704 | ▲2.648 |
| Operating Cash Flow Coverage Ratio | 0.381 | ▲0.216 | ▲0.176 |
| Capital Expenditure Coverage Ratio | 1.242 | ▲0.640 | ▲0.365 |
| Dividend Paid And Capex Coverage Ratio | 1.242 | ▲0.640 | ▲0.365 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 18.118 | ▲10.592 | ▲6.297 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $1.25B | $470.0M | $585.6M | $443.2M | $359.5M | |
| Enterprise value | $1.47B | $654.2M | $730.0M | $623.7M | $519.5M | |
| EV / Sales | 2.32x | 1.09x | 1.17x | 1.13x | 1.34x | |
| EV / Op. cash flow | 14.61x | 17.91x | 10.40x | 32.90x | 111.55x | |
| EV / Free cash flow | 75.04x | -27.08x | 22.77x | -29.56x | -32.72x | |
| EV / EBITDA | 18.12x | 7.53x | 8.26x | 10.43x | 14.78x | |
| Net debt / EBITDA | 2.69x | 2.12x | 1.63x | 3.02x | 4.55x | |
| Current ratio | 2.02x | 2.19x | 2.24x | 1.92x | 2.17x | |
| Income quality | 23.86x | 0.32x | 2.75x | 2.48x | -0.28x | |
| Graham number | $1 | $6 | $2 | $1 | — | |
| Graham net-net | -$3 | -$2 | -$1 | -$2 | -$1 | |
| Tax burden | 11.3% | 376.7% | 81.3% | 70.2% | 114.1% | |
| Interest burden | 60.5% | 56.1% | 58.6% | 41.4% | -888.9% | |
| Working capital | $160.2M | $146.3M | $156.1M | $114.2M | $113.2M | |
| Invested capital | $412.9M | $343.2M | $324.8M | $282.5M | $276.2M | |
| Return on assets | 0.4% | 15.1% | 5.2% | 1.7% | -4.2% | |
| Operating ROA | 7.9% | 8.2% | 9.5% | 5.3% | -1.7% | |
| Return on tangible assets | 0.4% | 15.6% | 5.5% | 1.8% | -4.7% | |
| Return on equity | 1.1% | 42.5% | 17.4% | 7.3% | -16.9% | |
| Return on invested capital | 1.5% | 8.2% | 9.5% | 4.5% | -4.3% | |
| Return on capital employed | 9.5% | 8.4% | 12.2% | 6.8% | -4.4% | |
| Earnings yield | 0.2% | 23.0% | 4.4% | 1.8% | -4.7% | |
| Free cash flow yield | 1.6% | -5.1% | 5.5% | -4.8% | -4.4% | |
| Capex / Op. cash flow | 80.5% | 166.2% | 54.3% | 211.3% | 440.9% | |
| Capex / Depreciation | 217.9% | 169.9% | 111.1% | 122.1% | 61.3% | |
| Capex / Sales | 12.8% | 10.1% | 6.1% | 7.2% | 5.3% | |
| SG&A / Sales | 15.9% | 15.0% | 15.4% | 16.6% | 19.3% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Intangibles / Total assets | 2.7% | 3.5% | 5.8% | 7.2% | 9.3% | |
| Days sales outstanding | 3d | 64d | 65d | 86d | 86d | |
| Days payables outstanding | 42d | 34d | 39d | 41d | 42d | |
| Operating cycle | 3d | 145d | 138d | 145d | 163d | |
| Cash conversion cycle | -39d | 110d | 98d | 105d | 120d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+165.6%EV / Sales ▲+112.8%EV / EBITDA ▲+140.8%EV / Op. cash flow ▼-3.303Earnings yield ▼-0.228Graham number ▼-4.959
Profitability
Return on equity ▼-0.415Return on assets ▼-0.147Return on invested capital ▼-0.067Return on capital employed ▲+0.011Operating ROA ▼-0.003Income quality ▲+23.534Tax burden ▼-3.654
Efficiency
Days sales outstanding ▼-60.509Days payables outstanding ▲+7.999Operating cycle ▼-141.353Cash conversion cycle ▼-149.352Capex / Sales ▲+0.027R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.162Net debt / EBITDA ▲+0.577Working capital ▲+13936000.000Invested capital ▲+69715000.000Intangibles / Total assets ▼-0.007
Change over 5 years
Valuation
Market cap ▲+247.1%EV / Sales ▲+73.7%EV / EBITDA ▲+22.6%EV / Op. cash flow ▼-96.937Earnings yield ▲+0.049
Profitability
Return on equity ▲+0.179Return on assets ▲+0.046Return on invested capital ▲+0.057Return on capital employed ▲+0.138Operating ROA ▲+0.096Income quality ▲+24.134Tax burden ▼-1.028
Efficiency
Days sales outstanding ▼-82.389Days payables outstanding ▲+0.099Operating cycle ▼-159.175Cash conversion cycle ▼-159.274Capex / Sales ▲+0.075R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.142Net debt / EBITDA ▼-1.853Working capital ▲+46967000.000Invested capital ▲+136719000.000Intangibles / Total assets ▼-0.065
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-09-03 Thiogenesis Engages Brisco Capital for Investor Relations San Diego, California--(Newsfile Corp. - September 3, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQB: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing sulfur-based therapeutics for rare diseases, today announced that it has engaged Brisco Capital Partners Corp. ("Brisco") to provide investor relations services. Brisco will assist the Company in expanding communications with shareholders, investors and the broader investment community to increase awareness of Thiogenesis and its development programs.
- 2026-09-02 TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES SPRING, Texas, Sept. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced that Brady Murphy, Chief Executive Officer, and Kurt Hallead, Treasurer and VP of Investor Relations, will be meeting with institutional investors at the following conferences: September 9, 2026: Barclays 40th Annual Energy-Power Conference (NY, NY) September 10, 2026: Jefferies Renewables, Clean Energy and E&C Conference (NY, NY) TETRA''s most recent presentation is available on its Investor Relations site.
- 2026-08-31 Technip Energies (OTCMKTS:THNPY) versus Tetra Technologies (NYSE:TTI) Critical Contrast Technip Energies (OTCMKTS:THNPY - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Report) are both energy companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk. Valuation and Earnings This table compares Technip Energies
- 2026-08-19 Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript
- 2026-08-09 Tetra Technologies Q2 Earnings Call Highlights Tetra Technologies NYSE: TTI reported second-quarter revenue of $185.7 million, up 19% sequentially and 7% from the prior-year period, as strength in international and offshore operations offset delayed Middle East fluid shipments tied to regional conflict.
- 2026-08-07 Tetra Technologies (TTI) Reports Q2 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 2026-08-04 TETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript TETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript
- 2026-08-03 Tetra Technologies (TTI) Q2 Earnings Meet Estimates Tetra Technologies (TTI) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago.
- 2026-08-03 Compared to Estimates, Tetra Technologies (TTI) Q2 Earnings: A Look at Key Metrics Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 2026-08-03 TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS SPRING, Texas, Aug. 3, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced financial results for the three and six months ended June 30, 2026. Second-Quarter 2026 Financial Highlights Revenues of $185.7 million Income from continuing operations of $10.2 million, inclusive of $1.1 million of unusual charges Adjusted EBITDA of $31.9 million Net Income per share from continuing operations of $0.07, adjusted net income per share of $0.08 Launched TETRA Neptune Z-Lite, awarded a three-well Gulf of America Deepwater Project Raised $108 million of net proceeds related to the equity offering Board of Directors approved final investment decision ("FID") for the Arkansas Bromine Project Brady Murphy, TETRA''s President and Chief Executive Officer, stated, "We delivered one of our strongest second-quarter and first-half financial performances in the past decade, reflecting the strength of our base business and our ability to grow in deepwater and international markets.